Isradipine
- Generic Name
- Isradipine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H21N3O5
- CAS Number
- 75695-93-1
- Unique Ingredient Identifier
- YO1UK1S598
- Background
Isradipine belongs to the dihydropyridine (DHP) class of calcium channel blockers (CCBs), the most widely used class of CCBs. It is structurally related to felodipine, nifedipine, and nimodipine and is the most potent calcium-channel blocking agent of the DHP class. Isradipine binds to calcium channels with high affinity and specificity and inhibits calcium ...
- Indication
用于防治高血压、冠心病、心绞痛和充血性心力衰竭。
- Associated Conditions
- Hypertension
- Associated Therapies
- -
Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation
- Conditions
- Interventions
- First Posted Date
- 2017-03-20
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- University of Texas at Austin
- Target Recruit Count
- 78
- Registration Number
- NCT03083353
- Locations
- 🇺🇸
University of Texas at Austin, Austin, Texas, United States
Efficacy of Isradipine in Early Parkinson Disease
- Conditions
- Interventions
- First Posted Date
- 2014-06-20
- Last Posted Date
- 2020-01-14
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 336
- Registration Number
- NCT02168842
- Locations
- 🇺🇸
University of California, Irvine, California, United States
🇺🇸University of Rochester, Rochester, New York, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
Impact of Persistent Conductances on Motor Unit Firing in SCI
- Conditions
- Interventions
- First Posted Date
- 2014-05-13
- Last Posted Date
- 2014-05-13
- Lead Sponsor
- Shirley Ryan AbilityLab
- Target Recruit Count
- 50
- Registration Number
- NCT02136823
Improving Buprenorphine Detoxification Outcomes With Isradipine
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2017-06-05
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 28
- Registration Number
- NCT01895270
- Locations
- 🇺🇸
UAMS Psychiatric Research Institute, Little Rock, Arkansas, United States
Adjunctive Isradipine for the Treatment of Bipolar Depression
- First Posted Date
- 2013-02-06
- Last Posted Date
- 2017-04-20
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 2
- Registration Number
- NCT01784666
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder
- First Posted Date
- 2012-08-06
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 11
- Registration Number
- NCT01658150
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Drug Discrimination in Methadone-Maintained Humans Study 1
- Conditions
- Interventions
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2011-03-11
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 40
- Registration Number
- NCT00593463
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.